Cargando…
Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
Introduction: As the prevalence of kidney disease continues to rise worldwide, there is accumulating evidence that kidney injury and dysfunction, whether acute or chronic, is associated with major adverse outcomes, including mortality. Meanwhile, effective therapeutic options in the treatment of acu...
Autores principales: | Chua, Janice T., Argueta, Donovan A., DiPatrizio, Nicholas V., Kovesdy, Csaba P., Vaziri, Nosratola D., Kalantar-Zadeh, Kamyar, Moradi, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653784/ https://www.ncbi.nlm.nih.gov/pubmed/31346545 http://dx.doi.org/10.1089/can.2018.0060 |
Ejemplares similares
-
Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019) -
Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016) -
Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity
por: DiPatrizio, Nicholas V.
Publicado: (2021) -
UPLC-MS/MS Method for Analysis of Endocannabinoid and Related Lipid Metabolism in Mouse Mucosal Tissue
por: Wiley, Mark B., et al.
Publicado: (2021) -
Inverse Association Between Serum Non–High‐Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis
por: Chang, Tae Ik, et al.
Publicado: (2018)